View Cart (0 items)

Pharmaceutical

Iowa attorney general sues drug firms

October 12, 2007
A lawsuit filed by Iowa Attorney General Tom Miller alleges that drug companies inflated prices of prescription drugs by millions of dollars causing state and federal governments to overpay for
Read More

Witty to be next GlaxoSmithKline CEO

October 8, 2007
According to the Associated Press, GlaxoSmithKline PLC has selected the president of its European pharmaceuticals division, Andrew Witty, to succeed Jean-Pierre Garnier as its chief executive officer. Witty, 43, who
Read More

Pfizer faces $8.5 billion suit over Nigeria drug trial

October 1, 2007
A court case brought by Nigeria against Pfizer resumes on Wednesday with the U.S. drug maker saying it answered a call for help to save the lives of African children
Read More

Bristol-Myers to buy Adnexus for $430 million

September 24, 2007
Drug maker Bristol-Myers Squibb Co. said it will acquire privately-held Adnexus Therapeutics in a $430 million all-cash deal, the Associated Press reports. Biotechnology company Adnexus Therapeutics will become a subsidiary
Read More

Johnson & Johnson to cut 688 jobs at Janss

September 18, 2007
The Associated Press reports that Belgian pharmaceutical maker Janssen-Cilag will eliminate 688 jobs as it seeks to put more money into research and development, and as exclusive patent rights to
Read More

Accenture, Bristol-Myers open drug safety center in India

September 14, 2007
Accenture Ltd., a consulting, technology services and outsourcing firm, has opened a joint center to monitor drug safety data in India with Bristol-Myers Squibb Co., according to the Associated Press.
Read More

Supreme Court rejects Vioxx class action

September 11, 2007
In a major legal victory for Merck & Co. in its massive Vioxx litigation, New Jersey''s Supreme Court recently rejected a potential class-action lawsuit that could have cost the drugmaker
Read More

Sigma-Aldrich to expand Wisconsin plant

September 10, 2007
The Associated Press reports that a pharmaceutical products subsidiary of Sigma-Aldrich Corp. is planning a $4.5 million expansion of its chemical manufacturing facility in Madison, Wisconsin. The plan, scheduled for
Read More

Pfizer Hires D''Amelio as CFO

August 28, 2007
Drug developer Pfizer Inc. said Frank D''Amelio, an executive with communications equipment company Alcatel-Lucent, will become the company''s new chief financial officer in mid-September replacing Alan Levin, according to the
Read More

Merck CFO sells 63,000 shares of stock

August 6, 2007
The Associated Press reports that executive vice president and chief financial officer of drug developer Merck & Co. sold 63,000 shares of common stock, according to a Securities and Exchange
Read More